DMD Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foth, H.
Right arrow Articles by Kahl, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foth, H.
Right arrow Articles by Kahl, G. F.

Pulmonary elimination and metabolism of 5-fluoro-2'-deoxyuridine in isolated perfused rat lung and lung slices

H Foth, J Hellkamp, EM Kunellis and GF Kahl

Department of Pharmacology and Toxicology, University of Gottingen, FRG.

Elimination kinetics and metabolism of the cytostatic drug 5-fluoro-2'- deoxyuridine (FUDR) were studied in isolated perfused rat lung and in incubated lung slices. The intact organ exhibited a low clearance of 0.2 to 0.8 ml/min and a calculated first-pass extraction of 2 to 7% of the drug inflow. Thus, the pulmonary uptake of the fluorinated nucleoside from the circulation is low. Within 120 min of perfusion, however, 30 to 45% of the initial FUDR dose was metabolized by the isolated rat lung. The nucleobase metabolite 5-fluorouracil (FU) represented almost all FUDR metabolites in the medium, indicating that this metabolic pathway, mediated by thymidine phosphorylase, is active in lung while the enzymic activity for further pyrimidine degradation is low. This was demonstrated in incubated lung slices, which have a high capacity to transform FUDR into FU, comprising 83 to 95% of the metabolites in the medium. The final catabolic metabolite, alpha-fluoro- beta-alanine, was present in trace amounts only. It is concluded that the pulmonary tissue contains a marked "intrinsic" capacity to transform FUDR into FU, while the metabolic activity for catabolism of the nucleobase metabolites FU and 5,6-dihydrouracil is virtually lacking.

Volume 18, Issue 6, pp. 1011-1017, 11/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J Clin PharmacolHome page
H. Jiang, J. Lu, J. Jiang, and P. Hu
Important Role of the Dihydrouracil/Uracil Ratio in Marked Interpatient Variations of Fluoropyrimidine Pharmacokinetics and Pharmacodynamics
J. Clin. Pharmacol., November 1, 2004; 44(11): 1260 - 1272.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. L. Port, B. Ng, J. L. Ellis, S. Nawata, J. T. Lenert, and M. E. Burt
Isolated Lung Perfusion With FUDR in the Rat: Pharmacokinetics and Survival
Ann. Thorac. Surg., September 1, 1996; 62(3): 848 - 852.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
B. Ng, J. T. Lenert, B. Weksler, J. L. Port, J. L. Ellis, and M. E. Burt
Isolated Lung Perfusion With FUDR Is an Effective Treatment for Colorectal Adenocarcinoma Lung Metastases in Rats
Ann. Thorac. Surg., January 1, 1995; 59(1): 205 - 208.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.